Norbrook Laboratories Ltd. manufactures and distributes veterinary pharmaceutical products. The firm offers medical, chemical, veterinary, and consumer division products. The company was founded in 1969 and is headquartered in Newry, the United Kingdom.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Baxter Healthcare SA engages in the development, production, and sale of healthcare systems and products. It also acquires and manages participations in pharmaceutical-chemical firms. The company was founded on December 7, 2000 and is headquartered in Glattpark, Switzerland.

Biodel Inc. (Biodel) is a development-stage company. The Company is a biopharmaceutical company focused on the development and commercialization of treatments for diabetes. It develops its product candidates by applying its formulation technologies to existing drugs. Its product candidate is Linjeta. It has formulated Linjeta as rapid-acting mealtime insulin for the treatment of patients with Type I and Type II diabetes. Earlier stage product candidates include follow-on and second generation rapid-acting mealtime insulins or insulin analogs, VIAtab, a sublingual tablet formulation of insulin, a line of basal insulins, and a formulation of glucagon.

Sanofi is a global healthcare company. Among their duties are researching disease causes, determining starting points for drug treatment, developing drugs, producing active ingredients, and delivering finished drugs and active ingredients. Specialists in vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare.

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert in 1950 and headquartered in Irvine, CA.

Troikaa Pharmaceuticals Ltd. is an Indian private company located in Ahmedabad. The firm manufactures and supplies pharmaceutical products. It was founded in 1994.

Embecta is a provider of diabetes healthcare services. They improve the lives of people living with diabetes. The care is in insulin delivery through strong community partnerships, innovative technology, and comprehensive care resources. For inquiries, email and phone numbers are available on their websites.

Baxalta GmbH, a subsidiary of Takeda Pharmaceutical Co., Ltd., is a Swiss company located in Glattpark that manufactures and wholesales pharmaceutical products. It was founded in 2000. Julie So-Young Kim is currently the CEO of the firm.

Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL.

Xi’an Libang Enterprises, established in 1996, a hi-tech biopharmaceutical-oriented corporate group specialized in the development, production and distribution of pharmaceutical products and healthy nutrition products, also presenting in the cultural industry.

GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.

Oncos Therapeutics develops new cancer therapies based on its next generation oncolytic viruses. The company's unique Advanced Therapy Access Program was started in 2007 for cancer patients in whom standard-of-care therapies have failed. Today, 200 patients have undergone individually tailored oncolytic virus therapy suggesting strong safety and efficacy. The program is based on extensive scientific research at the University of Helsinki and serves as the foundation for ongoing clinical development.

Xi'an Libang Pharmaceutical Co., Ltd. Baoji Plant, established on 2008-03-11, Business scope includes raw materials[Lecithin Complex Iodine,Ligustrazine Hydrochloride,meglumine,Diatrizoic acid,Propofol,Carboxymethyl Starch Sodium(Slurry)},oral solution,large volume injection,Pharmaceutical excipient {lecithin(for injection),Oleic acid(for injection),sodium oleate(for injection)egg yolk phosphatidylcholine},oral suspension production;Production of fine chemical products,to develop,Sales;Technical consulting services for medical and health products;Operating the export business of self-produced products and related technologies of the enterprise and its members(Except for goods that the state restricts the company to operate or prohibits export);Operating the enterprise and the production of its members,Raw materials for scientific research,Equipment,Instrumentation,Import business of spare parts and related technologies(Except for goods that the state restricts the company to operate or prohibits imports);Operating the enterprise's processing with imported materials and"Three to one make up"business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanjing Ruizhi Biomedical Co., Ltd., established on 2020-03-12, Business scope includes licensed projects:pharmaceutical production;Drug retail(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Socioeconomic Advisory Services;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Biochemical product technology research and development;Health Consulting Services(Does not include medical services)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Beijing Renfu Medical Equipment Co., Ltd., established on 2014-06-23, Business scope includes sales of medical devices(Ι,Class II),computer,Software and Auxiliary Equipment,car,hardware products(E-bike not included),household appliances,daily necessities,electronic product,stationery,Chemical Products(No licensed chemical products),communication equipment,arts and crafts,hygiene products,condom,contraceptive cap,early pregnancy test strips,early pregnancy test pen,Early pregnancy test kit,cosmetic,Disinfectant(Free of Hazardous Chemicals);Medical Equipment Leasing;technology development,consult,Serve,transfer,to promote;Import and export;Technology Import and Export;software development;Repair office equipment,Instrumentation;business management;property management;Undertake the exhibition;Socioeconomic Counseling;Conference Services(No board and lodging);Landscaping project;Organize cultural and artistic exchange activities(without show);Warehousing Services;Agent import and export;lease commercial premises;Medical Device Repair;sell food;Internet information service;wholesale medicine;Sales of Class III Medical Devices(The business scope is subject to the medical device operating enterprise license)(The medical device business license is valid until2025year11moon04day);General cargo,Dedicated transport of goods(Refrigerated)(The road transport business license is valid until2025year05moon10day).(Market entities independently choose business projects in accordance with the law,Carry out business activities;sell food,Internet information service,Wholesale pharmaceuticals and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. - The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. - The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. - The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is headquartered in Deerfield, Illinois.

Hunan Taigu Biological Veterinary Medicine Co., Ltd., established on 2011-12-27, Business scope includes feed research and development;Feed additives,additive premixed feed,veterinary medicine,compound feed,Concentrate supplement,Production of concentrated feed;Veterinary drug business;feed retail;Livestock and Fishery Feed Wholesale.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of drugs. It specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs. The firm’s products include tablets, oral solution, and suspension of antineoplastic drugs and narcotic drugs; psychotropic substances; soft capsules; freeze-dried powder injection; powder injection; high-volume injection, including multi-layer co-extruded infusion bag, with anti-tumor drugs; small volume injections, including antineoplastic drugs, psychotropic drugs, and non-final sterilization; biological engineering products such as polyethylene glycol recombinant human granulocyte stimulating factor injection; hard capsules; granules; powder; and film and gel. The company was founded in 1970 and is headquartered in Lianyungang, China.